Research and Markets (http://www.researchandmarkets.com/research/q3sbxr/botulism)
has announced the addition of the "Botulism
- Pipeline Review, H1 2014" report to their offering.
This report provides comprehensive information on the therapeutic
development for Botulism, complete with comparative analysis at various
stages, therapeutics assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type, along with
latest updates, and featured news and press releases. It also reviews
key players involved in the therapeutic development for Botulism and
special features on late-stage and discontinued projects.
Drug profiles/records featured in the report undergoesperiodic updation
following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
For more information visit http://www.researchandmarkets.com/research/q3sbxr/botulism
[ Back To NFVZone's Homepage ]